Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19314
Title: | Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme |
Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
Keywords: | Adolescent,Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/*administration &,dosage/*therapeutic use,Brain Neoplasms/*drug therapy/mortality/*radiotherapy,Cisplatin/*administration & dosage,Cyclophosphamide/*administration & dosage,Disease-Free Survival,Dose-Response Relationship, Drug,Eflornithine/*administration & dosage,Female,Glioblastoma/*drug therapy/mortality/*radiotherapy,Humans,Lomustine/*administration & dosage,Male,Middle Aged,Procarbazine/*administration & dosage,Prospective Studies,Time Factors,Vincristine/*administration & dosage,Vindesine/*administration & dosage |
URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19314 |
ISSN: | 1078-0432 |
Link: | http://www.ncbi.nlm.nih.gov/pubmed/11051233 http://clincancerres.aacrjournals.org/content/6/10/3878.full.pdf |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Levin-2000-Phase III randomized.pdf | 119.21 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License